This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Stephen M. Hahn, M.D., Commissioner of Food and Drugs

Event Date: 12/21/2020
Location: Las Vegas, NV
Subject: COVID-19 Efforts
FDA Participant/Group: N/A
Non FDA Participant/Group: Several members of Governor Steve Sisolak's office and Nevada's public health officials

Event Date: 12/22/2020
Location: Cheyenne, WY
Subject: COVID-19 Efforts
FDA Participant/Group: N/A
Non FDA Participant/Group: Several members of Governor Mark Gordon's office and Wyoming's public health officials

Event Date: 12/23/2020
Location: Virtual
Subject: COVID-19 Vaccines
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Janice Mathis, Johnetta Betsch Cole (National Council of Negro Women);

Event Date: 12/23/2020
Location: Virtual
Subject: COVID-19 Vaccines Process
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several members of United States Pharmacopeia

Official Name: Amy Abernethy, M.D., Ph.D, Principal Deputy Commissioner

No Significant Event

Official Name: Anand Shah, M.D., Deputy Commissioner for Medical and Scientific Affairs

No Significant Event

Official Name: Anna Abram, Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response

Event Date: 12/21/2020
Location: Virtual
Subject: Food Safety Education
FDA Participant/Group: CONRAD CHOINIERE; NINA ZIMDAHL;
Non FDA Participant/Group: Several members from Disney, the Partnership for Food Safety Education, and the United States Department of Agriculture

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

No Significant Event

Official Name: Judy McMeekin, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Heidi Rebello, Acting Associate Commissioner for External Affairs

No Significant Event

Official Name: RADM Denise Hinton, Chief Scientist

No Significant Event

Official Name: Patrizia Cavazzoni, M.D., Acting Director, Center for Drug Evaluation and Research

No Significant Event

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 12/22/2020
Location: Virtual
Subject: CBER 2021 Priorities
FDA Participant/Group: N/A
Non FDA Participant/Group: Members of the Alliance for a Stronger FDA

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

No Significant Event

Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition

No Significant Event

Official Name: Mitchell R. Zeller, J.D., Director, Center for Tobacco Products

No Significant Event

Official Name: Steven Solomon, Director, Center for Veterinary Medicine

No Significant Event

Official Name: William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research

No Significant Event

Official Name: Stacy Cline Amin, Chief Counsel

No Significant Event